IB4(+) nociceptors mediate persistent muscle pain induced by GDNF.
Skeletal muscle is a well-known source of glial cell line-derived neurotrophic factor (GDNF), which can produce mechanical hyperalgesia. Since some neuromuscular diseases are associated with both increased release of GDNF and intense muscle pain, we explored the role of GDNF as an endogenous mediator in muscle pain. Intramuscularly injected GDNF induced a dose-dependent (0.1-10 ng/20 μl) persistent (up to 3 wk) mechanical hyperalgesia in the rat. Once hyperalgesia subsided, injection of prostaglandin E(2) at the site induced a prolonged mechanical hyperalgesia (>72 h) compared with naïve rats (<4 h; hyperalgesic priming). Selective neurotoxic destruction of IB4(+) nociceptors attenuated both GDNF hyperalgesia and hyperalgesic priming. Ergonomic muscular injury induced by eccentric exercise or mechanical vibration increased muscle GDNF levels at 24 h, a time point where rats also exhibited marked muscle hyperalgesia. Intrathecal antisense oligodeoxynucleotides to mRNA encoding GFRα1, the canonical binding receptor for GDNF, reversibly inhibited eccentric exercise- and mechanical vibration-induced muscle hyperalgesia. Finally, electrophysiological recordings from nociceptors innervating the gastrocnemius muscle in anesthetized rats, revealed significant increase in response to sustained mechanical stimulation after local GDNF injection. In conclusion, these data indicate that GDNF plays a role as an endogenous mediator in acute and induction of chronic muscle pain, an effect likely to be produced by GDNF action at GFRα1 receptors located in IB4(+) nociceptors.
Departments of Oral and Maxillofacial Surgery, University of California, San Francisco, California 94143-0440, USA.
Pedro
P
Alvarez
Xiaojie
X
Chen
Oliver
O
Bogen
Paul G
PG
Green
Jon D
JD
Levine
D000818:Animals; D015232:Dinoprostone / Q000494:pharmacology; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000378:metabolism / Q000633:toxicity*; D051097:Glial Cell Line-Derived Neurotrophic Factor Receptors / Q000378:metabolism; D006930:Hyperalgesia / Q000139:chemically induced / Q000209:etiology / Q000378:metabolism; D008297:Male; D018482:Muscle, Skeletal / Q000503:physiopathology; D059352:Musculoskeletal Pain / Q000139:chemically induced / Q000209:etiology / Q000378:metabolism*; D009619:Nociceptors / Q000378:metabolism / Q000502:physiology*; D020319:Oligodeoxyribonucleotides, Antisense; D010805:Physical Conditioning, Animal; D012333:RNA, Messenger / Q000037:antagonists & inhibitors; D051381:Rats; D017207:Rats, Sprague-Dawley; D014732:Vibration
D051100:Glial Cell Line-Derived Neurotrophic Factor; D051097:Glial Cell Line-Derived Neurotrophic Factor Receptors; D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger; D015232:Dinoprostone